CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-21 | Litvack Frank Director | Shares withheld for taxes | −4,524 | $4.31 | $19K | 137,276 |
| 2023-02-21 | Litvack Frank Director | Option exercise · Stock Option (Right to Buy) | −14,027 | 0 | ||
| 2023-02-14 | DUNBAR GEORGE W JR Director | Option exercise | +1,401 | $1.39 | $2K | 10,556 |
| 2023-02-14 | DUNBAR GEORGE W JR Director | Option exercise · Stock Option (Right to Buy) | −1,401 | 0 | ||
| 2023-02-14 | COLLIER EARL M JR Director | Option exercise | +1,401 | $1.39 | $2K | 16,856 |
| 2023-02-14 | COLLIER EARL M JR Director | Option exercise · Stock Option (Right to Buy) | −1,401 | 0 | ||
| 2023-01-03 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +3,560 | 3,560 | ||
| 2023-01-03 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | Sabar Karimah Es Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2023-01-03 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +16,620 | 16,620 | ||
| 2023-01-03 | Musket David B Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +7,120 | 7,120 | ||
| 2023-01-03 | Manzo Louis Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2023-01-03 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +8,310 | 8,310 | ||
| 2023-01-03 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (Right to Buy) | +19,000 | 19,000 | ||
| 2023-01-03 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +37,770 | 37,770 | ||
| 2023-01-03 | COLLIER EARL M JR Director | Grant or award · Stock Option (Right to Buy) | +11,870 | 11,870 |
Page 10 of 24 · 468 trades